This thesis focuses on the design and development of novel antimicrobial nanoplatform to combat bacterial infections. We have designed and characterized several new nanoplatforms by integrating multiple materials such as nanoparticles, polymers, organic molecules and antibiotics to combat different types of bacteria. Chapter 1 provides a general introduction to antibacterial therapy including two strategies, one is drug-based antibacterial strategy, the other one is nanoparticle-based antibacterial strategy. For nanoparticle-based antibacterial strategy, nanoparticles serving as vehicles for drug delivery and nanoparticles with intrinsic antibacterial capacity such as photodynamic and photothermal ability will be introduced. And then atte...
Antibiotic-resistant bacteria are emerging pathogens whose resistance profiles generate a serious he...
Innovations in nanotechnology have had an immense impact on medicine, such as in drug delivery, tiss...
The rapid emergence of bacterial infections, including resistant bacteria or biofilms, is occurring ...
Injudicious use of antibiotics has been the main driver of severe bacterial non-susceptibility to co...
The search of novel antibacterial treatment modalities designed to face problems of an- tibiotic Mul...
Antibiotic resistance has become an undeniable burden on global health as we move further into the t...
Conventional drugs used for antibacterial therapy display several limitations. This is not due to an...
The wide spread of antibiotic resistance has been alarming in recent years and poses a serious globa...
Antibiotic vancomycin (Van) is often used as the drug of last resort to treat methicillin resistant ...
Recent developments in light‐controlled therapies (e.g., photodynamic and photothermal therapies) pr...
Nanomaterials-based hybrid nano therapy is gaining attraction as a promising way to treat intracellu...
Pathogenic microorganisms are gradually becoming resistant to antibiotics, thereby novel antimicrobi...
The development of antibiotics has played a significant role in combating the dreaded infectious dis...
Over the last 20 years, the number of pathogenic multi-resistant microorganisms has grown steadily, ...
Infectious diseases remain one of the leading causes of morbidity and mortality worldwide. The WHO a...
Antibiotic-resistant bacteria are emerging pathogens whose resistance profiles generate a serious he...
Innovations in nanotechnology have had an immense impact on medicine, such as in drug delivery, tiss...
The rapid emergence of bacterial infections, including resistant bacteria or biofilms, is occurring ...
Injudicious use of antibiotics has been the main driver of severe bacterial non-susceptibility to co...
The search of novel antibacterial treatment modalities designed to face problems of an- tibiotic Mul...
Antibiotic resistance has become an undeniable burden on global health as we move further into the t...
Conventional drugs used for antibacterial therapy display several limitations. This is not due to an...
The wide spread of antibiotic resistance has been alarming in recent years and poses a serious globa...
Antibiotic vancomycin (Van) is often used as the drug of last resort to treat methicillin resistant ...
Recent developments in light‐controlled therapies (e.g., photodynamic and photothermal therapies) pr...
Nanomaterials-based hybrid nano therapy is gaining attraction as a promising way to treat intracellu...
Pathogenic microorganisms are gradually becoming resistant to antibiotics, thereby novel antimicrobi...
The development of antibiotics has played a significant role in combating the dreaded infectious dis...
Over the last 20 years, the number of pathogenic multi-resistant microorganisms has grown steadily, ...
Infectious diseases remain one of the leading causes of morbidity and mortality worldwide. The WHO a...
Antibiotic-resistant bacteria are emerging pathogens whose resistance profiles generate a serious he...
Innovations in nanotechnology have had an immense impact on medicine, such as in drug delivery, tiss...
The rapid emergence of bacterial infections, including resistant bacteria or biofilms, is occurring ...